Zoekresultaten - Blaydorn, Lisa
- Toon 1 - 5 resultaten van 5
-
1
Long-term safety, tolerability, and efficacy of vismodegib in two patients with metastatic basal cell carcinoma and basal cell nevus syndrome door Weiss, Glen J., Tibes, Raoul, Blaydorn, Lisa, Jameson, Gayle, Downhour, Molly, White, Erica, Caro, Ivor, Von Hoff, Daniel D.
Gepubliceerd in 2011Text -
2
-
3
A phase Ib study of pembrolizumab plus chemotherapy in patients with advanced cancer (PembroPlus) door Weiss, Glen J, Waypa, Jordan, Blaydorn, Lisa, Coats, Jessica, McGahey, Kayla, Sangal, Ashish, Niu, Jiaxin, Lynch, Cynthia A, Farley, John H, Khemka, Vivek
Gepubliceerd in 2017Text -
4
Safety, antitumor activity, and pharmacokinetics of dostarlimab, an anti-PD-1, in patients with advanced solid tumors: a dose–escalation phase 1 trial door Patnaik, Amita, Weiss, Glen J., Rasco, Drew W., Blaydorn, Lisa, Mirabella, Amy, Beeram, Murali, Guo, Wei, Lu, Sharon, Danaee, Hadi, McEachern, Kristen, Im, Ellie, Sachdev, Jasgit C.
Gepubliceerd in 2021Text -
5
Phase I study of the safety, tolerability and pharmacokinetics of PHA-848125AC, a dual tropomyosin receptor kinase A and cyclin-dependent kinase inhibitor, in patients with advance... door Weiss, Glen J., Hidalgo, Manuel, Borad, Mitesh J., Laheru, Daniel, Tibes, Raoul, Ramanathan, Ramesh K., Blaydorn, Lisa, Jameson, Gayle, Jimeno, Antonio, Isaacs, Jeffrey D., Scaburri, Angela, Pacciarini, Maria Adele, Fiorentini, Francesco, Ciomei, Marina, Von Hoff, Daniel D.
Gepubliceerd in 2011Text